Angelo Gordon & Co., L.P. Surmodics Inc Transaction History
Angelo Gordon & Co., L.P.
- $136 Million
- Q3 2024
A detailed history of Angelo Gordon & Co., L.P. transactions in Surmodics Inc stock. As of the latest transaction made, Angelo Gordon & Co., L.P. holds 21,160 shares of SRDX stock, worth $841,110. This represents 0.6% of its overall portfolio holdings.
Number of Shares
21,160
Previous 25,000
15.36%
Holding current value
$841,110
Previous $1.05 Million
21.98%
% of portfolio
0.6%
Previous 0.84%
Shares
2 transactions
Others Institutions Holding SRDX
# of Institutions
126Shares Held
11.8MCall Options Held
1.4KPut Options Held
8.6K-
Black Rock Inc. New York, NY1.17MShares$46.5 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.04MShares$41.4 Million0.01% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA989KShares$39.3 Million14.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$31.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY753KShares$29.9 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $557M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...